John Frankovitch, Weirton’s president and CEO since 2016, will retire at the end of the year, according to a news release from Weirton Medical Center shared with Becker’s Nov. 1.
David Artman was appointed next president and CEO, effective Jan. 1. Mr. Artman joined the hospital in 2012 and currently serves as COO, according to his LinkedIn page.
Following his 27-year career with the Weirton Medical Center, Mr. Frankovitch will serve as president emeritus of the board of trustees and as a strategic advisor. In this capacity, he will assist with strategic and integration efforts between the hospital and WVU Medicine, the release said.
Weirton Medical Center, a 238-bed acute care hospital, has had a clinical partnership with WVU Medicine since 2020. The hospital signed a letter of intent to join the system earlier this year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
